Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Cell Signal ; 30: 118-129, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27915047

RESUMEN

The L-type Ca2+ channel (LTCC) Cav1.3 plays a critical role in generating electrical activity in atrial myocytes and cardiac pacemaker cells. However, the molecular and functional basis of Cav1.3 modulation in atrial myocytes has not yet been fully understood. By using the yeast two-hybrid system (Y2H), a Cav1.3-associated protein was screened, which was identified as Snapin. Physical interaction and co-localization between Snapin and Cav1.3 were then confirmed in both the heterologous expression system and mouse atrial myocytes. Direct interaction between them was additionally addressed in a GST pull down assay. Furthermore, both total and membrane expressions of Cav1.3 were significantly impaired by Snapin overexpression, resulting in the ubiquitin-proteasomal degradation of Cav1.3 and a consequent reduction of the densities of whole-cell ICa-L. Snapin-induced down-regulation of Cav1.3 was reversed by SNAP-23 competitively. What is more important is that the depressed-expression of Cav1.3 paralleled with enhanced-expression of Snapin was documented in atrial samples from atrial fibrillation (AF) patients. Our results provide the evidence of a direct regulatory role of Snapin on Cav1.3 channels in atrial myocytes, and highlight a potential role of Snapin in the regulation of Cav1.3 in atrial arrhythmogenesis.


Asunto(s)
Canales de Calcio Tipo L/metabolismo , Atrios Cardíacos/citología , Miocitos Cardíacos/metabolismo , Proteínas de Transporte Vesicular/metabolismo , Adulto , Animales , Fibrilación Atrial/metabolismo , Fibrilación Atrial/patología , Membrana Celular/metabolismo , Femenino , Células HEK293 , Humanos , Activación del Canal Iónico , Masculino , Ratones Endogámicos C57BL , Persona de Mediana Edad , Unión Proteica , Transporte de Proteínas , Proteínas Qb-SNARE/metabolismo
2.
Basic Clin Pharmacol Toxicol ; 117(3): 180-5, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25641661

RESUMEN

Cancer-induced bone pain (CIBP) is seriously disruptive to the quality of life in cancer patients, and present therapies are limited. The Bv8/prokineticin 2, a new family of chemokines, has been demonstrated to be involved in inflammatory and neuropathic pain. However, whether it is involved in CIBP remains unclear. This study was designed to examine whether spinal Bv8 was involved in the development of CIBP in rats. A rat CIBP model was constructed by injecting Walker 256 carcinoma cells into the medullary cavity of rat tibia. Tibia inoculation with Walker 256 tumour cells resulted in the development of mechanical hyperalgesia. Compared with sham rats, spinal Bv8 mRNA and protein levels were markedly and time-dependently increased in CIBP rats. Intrathecal administration of Bv8 neutralizing antibody (5 ng) could markedly attenuate pain behaviour as well as up-regulation of spinal TNF-α expression at day 18 after inoculation. Intrathecal pre-treatment with synthetic Bv8 (50 pg) almost completely abolished these effects. These data suggested that spinal Bv8/prokineticin 2 participated in the development of CIBP. Targeting of spinal Bv8 might be a promising strategy for the management of cancer-induced bone pain.


Asunto(s)
Neoplasias Óseas/complicaciones , Hormonas Gastrointestinales/fisiología , Neuropéptidos/fisiología , Dolor/etiología , Animales , Western Blotting , Neoplasias Óseas/fisiopatología , Carcinoma 256 de Walker/patología , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Femenino , Hormonas Gastrointestinales/análisis , Metástasis de la Neoplasia , Trasplante de Neoplasias , Neuropéptidos/análisis , Dolor/fisiopatología , Dimensión del Dolor , Ratas , Ratas Sprague-Dawley , Reacción en Cadena en Tiempo Real de la Polimerasa , Médula Espinal/química , Factor de Necrosis Tumoral alfa/fisiología
3.
Yi Chuan ; 30(11): 1421-6, 2008 Nov.
Artículo en Chino | MEDLINE | ID: mdl-19073550

RESUMEN

Our early study found that goat spermatozoa could spontaneously take up foreign DNA and vary in capabilities of spermatozoa from different donors to bind and internalize exogenous DNA. In this study, three goats with considerable differences of capability were used to investigate the effect of exogenous DNA on goat spermatozoa, and feasibility and efficiency of transgenic embryo production by sperm-mediated gene transfer method. The viability, acrosomal reaction frequencies and cleavages were decreased in the groups co-cultured with exogenous DNA, compared with the control groups, and the range of decrease was correlated with the capability of sperm cells up-take foreign DNA. After fertilizing with co-cultured spermatozoa, GFP gene was introduced into oocytes and expressed in early embryos. However, different efficiencies of transgenic embryos appeared in sperm donors (P<0.05). GFP gene was detected in 16.2% (25/154), 5.3% (4/76), and 0% (0/36) embryos, respectively, when high, middle and low capability of sperm donors were used. But only 6.5% (10/154) embryos from high capability sperm donor expressed GFP. Our results demonstrate that selecting high capability of sperm donor is a key step for improving efficiency of sperm mediated-gene transfer method. However, the adverse influence of foreign DNA on spermatozoa needs to be further studied.


Asunto(s)
ADN/administración & dosificación , ADN/genética , Fertilización/genética , Técnicas de Transferencia de Gen , Cabras/embriología , Espermatozoides/citología , Espermatozoides/metabolismo , Animales , Animales Modificados Genéticamente , Transporte Biológico , Expresión Génica , Cabras/metabolismo , Proteínas Fluorescentes Verdes/genética , Masculino , Motilidad Espermática/genética , Transgenes/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...